✦ LIBER ✦

Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus

✍ Scribed by Sinha, V. P.; Howey, D. C.; Choi, S. L.; Mace, K. F.; Heise, T.

Book ID: 126161959
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 775 KB
Volume: 16
Category: Article
ISSN: 1462-8902
DOI: 10.1111/dom.12222

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Controlled Study of Once-D

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes

✍ Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 751 KB

Response to Comment on: Bergenstal et al

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

✍ Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 48 KB

Once-daily prandial lixisenatide versus

Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials

✍ Raccah, Denis; Lin, Jay; Wang, Edward; Germé, Maeva; Perfetti, Riccardo; Bonadon 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Use of rapid-acting insulin analogues in

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: Insulin pump therapy versus multiple daily injections

✍ Bruce W. Bode 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 216 KB

A 5-week study of the pharmacokinetics a

A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes

✍ P. Barrington; J. Y. Chien; H. D. H. Showalter; K. Schneck; S. Cui; F. Tibaldi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

PDB22 ECONOMIC EVALUATION OF LONG-ACTING

PDB22 ECONOMIC EVALUATION OF LONG-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE-1 AND TYPE-2 DIABETES MELLITUS IN CANADA

✍ D Belanger; CG Cameron 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB